Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Public ClinicalTrials.gov record NCT00879606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Study identification
- NCT ID
- NCT00879606
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Altor BioScience
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Interventions
- ALT-836 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2009
- Primary completion
- Sep 30, 2012
- Completion
- Dec 31, 2012
- Last update posted
- Apr 9, 2015
2009 – 2013
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Los Angeles County and USC Medical Center | Los Angeles | California | 90033 | — |
| UC Davis Medical Center | Sacramento | California | 95817 | — |
| Stanford University | Stanford | California | 94305 | — |
| Yale University | New Haven | Connecticut | 06520 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| West Suburban Hospital Medical Center | Oak Park | Illinois | 60302 | — |
| Illinois Lung and Critical Care Institute | Peoria | Illinois | 61606 | — |
| University of Iowa | Iowa City | Iowa | 52246 | — |
| Kentucky Lung Clinic | Hazard | Kentucky | 41701 | — |
| University of Louisville-Division of Pulmonary and Critical Care | Louisville | Kentucky | 40202 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | — |
| Saint Luke's Hospital | Kansas City | Missouri | 64111 | — |
| Saint Louis University | St Louis | Missouri | 63110 | — |
| Mercy Hospital St. Louis | St Louis | Missouri | 63141 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Piedmont Respiratory Research Foundation | Greensboro | North Carolina | 27310 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00879606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2015 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00879606 live on ClinicalTrials.gov.